{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:10:18Z","timestamp":1756379418503,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,8,9]]},"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare acquired neurological disorder characterized by opsoclonus, focal or diffuse myoclonus, truncal instability and associated other cerebellar signs and ataxia. While predominantly affecting children, it can rarely manifest in adults and could be associated with infections, paraneoplastic syndrome, drugs or other neurological disorders. We present a case of an elderly gentleman presenting with OMAS associated with a culture-positive urinary tract infection with <jats:italic>Escherichia coli<\/jats:italic>, successfully treated with antibiotics and immunoglobulins resulting in significant recovery.<\/jats:p>","DOI":"10.1136\/bcr-2024-261533","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:07:12Z","timestamp":1724375232000},"page":"e261533","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Opsoclonus-myoclonus-ataxia syndrome associated with bacterial urinary tract infection"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1602-6301","authenticated-orcid":false,"given":"Hasara","family":"Jayasekara","sequence":"first","affiliation":[{"name":"Postgraduate Institute of Medicine, University of Colombo, Colombo, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janitha Sampath","family":"Wickramarathne","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medicine, University of Colombo, Colombo, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damith Sanjaya","family":"Liyanage","sequence":"additional","affiliation":[{"name":"National Hospital, Karapitiya, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peduru Arachchige","family":"Jayasinghe","sequence":"additional","affiliation":[{"name":"National Hospital, Karapitiya, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"2025082803292499000_17.8.e261533.1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199206000-00002"},{"key":"2025082803292499000_17.8.e261533.2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3114"},{"key":"2025082803292499000_17.8.e261533.3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100106"},{"key":"2025082803292499000_17.8.e261533.4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","article-title":"Update on opsoclonus-myoclonus syndrome in adults","volume":"266","author":"Oh","year":"2019","journal-title":"J Neurol"},{"key":"2025082803292499000_17.8.e261533.5","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.1173"},{"key":"2025082803292499000_17.8.e261533.6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","article-title":"Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies","volume":"73","author":"Armangu\u00e9","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025082803292499000_17.8.e261533.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.03.005"},{"key":"2025082803292499000_17.8.e261533.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70272-5"},{"key":"2025082803292499000_17.8.e261533.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.2.279"},{"key":"2025082803292499000_17.8.e261533.10","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808324217"},{"key":"2025082803292499000_17.8.e261533.11","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-011-0098-6"},{"key":"2025082803292499000_17.8.e261533.12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X","article-title":"Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): A randomised, open-label, phase 3 trial","volume":"2","author":"de Alarcon","year":"2018","journal-title":"Lancet Child Adolesc Health"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-261533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:29:32Z","timestamp":1756376972000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-261533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":12,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,22]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1136\/bcr-2024-261533"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-261533","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}